BD MAX™ MRSA XTwith eXTended Detection Technology for Newly Discovered MRSA Strains
INTRODUCING
BD MAX™ MRSA XTA better assay design for better patient safety at lower healthcare costs
• • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • •HAI
• Reduce the risk of transmission due to new and emerging strains of MRSA
- New MREJ types, not detected by other molecular assays1
- MRSA strains with the novel mecC gene, account for 3 to 4% of all cases2
• Avoid cost and patient impact associated with unnecessary isolation and treatment due to mecA dropouts
- Up to 18% of all positive MRSA results, reported by other molecular assays, may actually be false positives3,4,5
- Patients wrongly identified as carriers may acquire MRSA when cohorted with true carriers4
BD DiagnosticsTullastrasse 8-1269126, Heidelberg,Germanywww.bd.com/europe/ds
For more information, please contact [email protected] or visit our website: www.bd.com/europe/ds
1 Data on File
2 Petersen et al., Epidemiology of methicillin-resistant Staphylococcus aureus carrying the novel mecC gene in Denmark corroborates a zoonotic reservoir with transmission to humans Clin Micro Infect 2013; 19:E16-E22
3 Arbefeville et al. Prevalence and Genetic Relatedness of Methicillin-Susceptible Staphylococcus aureus Isolates Detected by the Xpert MRSA Nasal Assay J. Clin. Microbiol. 2011; 49:2996-2999
4 Blanc et al., High Proportion of Wrongly Identified Methicillin-Resistant Staphylococcus aureus Carriers by Use of a Rapid Commercial PCR Assay Due to Presence of Staphylococcal Cassette Chromosome Element Lacking the mecA Gene J. Clin. Microbiol. 2011; 49:722-724
5 Farley et al., Comparison of the BD GeneOhm Methicillin-Resistant Staphylococcus aureus (MRSA) PCR Assay to Culture by Use of BBL CHROMagar MRSA for Detection of MRSA in Nasal Surveil-lance Cultures from an At-Risk Community Population J. Clin. Microbiol. 2008; 46:743-746
BD, BD Logo and BD MAX are trademarks of Becton, Dickinson and Company. © 2013 BD XEUR5243-13 Printed in Europe November 2013
Simple Efficient Workflow
• Results in about 2 hours, compared to 2-4 days for culture
• Combine MRSA XT testing in the same run as StaphSR, Cdiff and other assays
&
BD MAX™ MRSA XT
PERFORMANCE
BD MAX™ MRSA XT
CULTURE
PCR POS NEG TOTAL
POS 149 54 203
NEG 11 2138 2149
TOTAL 160 2192 2352
Sensitivity: 93.1% Specificity: 97.5%
BD MAX™ MRSA XT performance compared to Combined (direct and enriched) Culture for MRSA1
Product Description
BD MAX™ MRSA XT (24 tests)
BD MAX™ PCR Cartridges
Catalog Number
443461
437519
LOAD GOand
S IMPLY
SNAP
RegulatoryStatus*
CE-IVD
CE-IVD
* CE-IVD: CE marked in compliance with the European In Vitro Diagnostic Medical Device Directive 98/79/EC